| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2008 | WO2008030260A3 Treatment of variola viral infections using a tissue factor inhibitor |
| 06/26/2008 | WO2008027445A3 Combination with bis(thiohydrazide amides) for treating cancer |
| 06/26/2008 | WO2008024398A3 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | WO2008021549A3 Methods and compositions for topoisomerase i modulated tumor suppression |
| 06/26/2008 | WO2008019394A3 Methods for treatment and diagnosis of psychiatric disorders |
| 06/26/2008 | WO2008016633A3 Combination therapy |
| 06/26/2008 | WO2008016378A3 Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue |
| 06/26/2008 | WO2008014311A3 Inhibitors of undecaprenyl pyrophosphate synthase |
| 06/26/2008 | WO2008011521A3 Polycyclic viral inhibitors |
| 06/26/2008 | WO2008011154A3 Formulations for benzimidazolyl pyridyl ethers |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2008006051A3 Bicyclic heteroaryl inhibitors of pde4 |
| 06/26/2008 | WO2008006050A3 Bicyclic heteroaryl inhibitors of pde4 |
| 06/26/2008 | WO2008005353A3 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 06/26/2008 | WO2008005232A3 Aerosol paint composition with fungicide and sprayable aerosol composition |
| 06/26/2008 | WO2008003769A3 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | WO2008002490A3 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| 06/26/2008 | WO2008000780A3 Inhalant powder containing phenylalanine |
| 06/26/2008 | WO2007143317A3 Compounds and methods for modulating expression of crp |
| 06/26/2008 | WO2007143316A3 Compounds and methods for modulating expression of sglt2 |
| 06/26/2008 | WO2007143185A3 Transdermal treatment of tendinopathy using glyceryl trinitrite |
| 06/26/2008 | WO2007135193A3 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means |
| 06/26/2008 | WO2007126990A3 Dietary supplements containing probiotics |
| 06/26/2008 | WO2007123847A3 Treatment of melanoma |
| 06/26/2008 | WO2007119177A3 Modified release formulations and methods of treating inflammatory bowel disease |
| 06/26/2008 | WO2007118335A9 Hepoxilin analog enantiomers |
| 06/26/2008 | WO2007118149A3 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers |
| 06/26/2008 | WO2007118001A8 Azoxystrobin formulations |
| 06/26/2008 | WO2007117686A3 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 |
| 06/26/2008 | WO2007117639A3 Synthesis of tetracyclines and analogues thereof |
| 06/26/2008 | WO2007117466A3 Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors |
| 06/26/2008 | WO2007117401A3 Indoles and benzoimidazoles as modulators of the histamine h4 receptor |
| 06/26/2008 | WO2007106912A3 Peroxisome-proliferator activated receptor-alpha agonists for organ preservation |
| 06/26/2008 | WO2007103221A3 An improved process for the preparation of armodafinil |
| 06/26/2008 | WO2007101005A3 Compositions and methods for effecting controlled posterior vitreous detachment |
| 06/26/2008 | WO2007089857A3 Substituted imidazole derivatives and their use as ptpase inhibitors |
| 06/26/2008 | WO2007075605A3 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 06/26/2008 | WO2007075597A3 Cosmetology product for skin and hair |
| 06/26/2008 | WO2007073175A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 06/26/2008 | WO2007070840A8 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/26/2008 | WO2007062862A3 Use of calmodulin inhibitors for the treatment of neurodegenerative disorders |
| 06/26/2008 | WO2005115410A3 Context dependent inhibitors of cytidine deaminases and uses thereof |
| 06/26/2008 | WO2005107801A3 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors and/or ucp and/or fas antibodies |
| 06/26/2008 | US20080154210 Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds |
| 06/26/2008 | US20080154199 Treating an allergic emergency by automatically injecting a first dose of epinephrine and, optionally subsequently, manually injecting a second dose from the same device; both doses have a volume of 0.3 mL of 1 mg epinephrine/ mL of solution; antianaphylactic agents; suitable for children (>12yrs); kits |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080153921 Amphipathic, lipophilic anti-oxidants, made into potent abzyme inhibitors by increasing solubility in aqueous solvents with lactoproteins; test solublized carotenoids, polyphenols, flavonoids, isoflavones, curcuminoids, ceramides to identify, obtain a composition which inhibits lipid oxidising abzymes |
| 06/26/2008 | US20080153920 Administration of nitric oxide donor with insufflation gas; increasing fetal cerebral oxygenation during laparoscopic procedure |
| 06/26/2008 | US20080153919 Milnacipran; sub-class of dual serotonin norepinephrine reuptake inhibitors characterized by a non-tricyclic structure and inhibit the reuptake of norepinephrine to an equal or greater extent than they inhibit the reuptake of serotonin; with gabapentin, pregabalin; no phenylalanine, tyrosine, tryptophan |
| 06/26/2008 | US20080153918 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing |
| 06/26/2008 | US20080153917 Sigma Receptor Ligands |
| 06/26/2008 | US20080153916 Use of Adamantyl Methoxydiphenyl Propenoic Acid For the Treatment of Acne |
| 06/26/2008 | US20080153915 Pharmaceutical Preparation For the Oral Cavity |
| 06/26/2008 | US20080153914 Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts |
| 06/26/2008 | US20080153913 Nutritional Supplement and Protocol |
| 06/26/2008 | US20080153912 Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin |
| 06/26/2008 | US20080153910 Lysine in therapeutic angiogenesis for cardiac and cerebral/neural reperfusion |
| 06/26/2008 | US20080153909 Eye drops to treat dry eyes; omega-3 fatty acid is alpha linolenic acid; omega-6 fatty acid is gammalinolenic acid; free of linoleic acid and arachidonic acid; surfactant, saline solution; adenexal inflammation |
| 06/26/2008 | US20080153908 Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition |
| 06/26/2008 | US20080153907 Pharmaceutical Composition for the Treatment of Cancer Comprising Lhm-Ra Complex |
| 06/26/2008 | US20080153906 Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System |
| 06/26/2008 | US20080153905 Esters of 2-phenylalkanenitriles and antifungal compositions containing them |
| 06/26/2008 | US20080153903 Including bisindolylmaleimide I - IV, calphostin C, chelerythrine chloride, ellagic acid, hypericin, K-252a, K-252b, K-252c, melittin, NGIC-I, phloretin, staurosporine, polymyxin B sulfate, protein kinase C inhibitor peptide 19-31 or 19-36, Ro-31-8220, Ro-32-0432, rottlerin, safingol, and sangivamycin |
| 06/26/2008 | US20080153902 E.g., 2 N-(2-Fluorophenyl)-5(S)-amino-4(S)-hydroxy-2(S)-isopropyl-7(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; renin inhibitors used for the treatment of hypertension, heart failure, glaucoma, myocardial infarction, kidney failure, restenoses or stroke |
| 06/26/2008 | US20080153901 Treating and/or preventing rosacea, common acne and/or seborrhoeic dermatitis. |
| 06/26/2008 | US20080153900 Administering an anti-microtubule agent such as campothecin, eleutherobin, sarcodictyins, epothilones, discodermolide, deuterium oxide, hexylene glycol, tubercidin or a taxane to treat diseases including psoriasis, arthritis, stenosis, graft rejection, vasculitis and inflammatory lung diseases |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153898 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 06/26/2008 | US20080153897 Administering creatine pyroglutamate to improve neuron health; improving cognitive functions and preventing and fighting the onset of stress and its deleterious effects on mental and physical performances. |
| 06/26/2008 | US20080153896 Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof |
| 06/26/2008 | US20080153895 Macrocyclic indole compounds, e.g., 16-cyclohexyl-3,6-dimethyl-17-phenyl-4,5,6,7,8,9-hexahydro-1H-13,15-(ethanediylidene)pyrrolo[2,1-f][1,2,7,10,13]thiatetraazacyclohexadecine-2,12(3H)-dione 10,10-dioxide; hepatitis C virus polymerase inhibitors |
| 06/26/2008 | US20080153894 Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| 06/26/2008 | US20080153893 Pyrazole Carboxamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153891 Synergistic anti-cancer compositions |
| 06/26/2008 | US20080153890 Phosphinic Amino Acid Compounds |
| 06/26/2008 | US20080153889 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)- 6-amino-2-(11-(nonyloxy)undec-8-enamido)hexanoic acid; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/26/2008 | US20080153888 Alpha-2-delta ligand/nsaid therapeutic treatment of lower urinary tract disorders |
| 06/26/2008 | US20080153887 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer |
| 06/26/2008 | US20080153886 4-Benzyl-[1,2,4]thiadiazolidine-3,5-dione or thione derivatives are used to treat nerve damage associated with prion diseases, Creutzfeld-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, muscular dystrophy, diabetic neuropathy, optic nerve injury, glaucoma, depression, bipolar disease, and ADT |
| 06/26/2008 | US20080153885 Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
| 06/26/2008 | US20080153883 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 06/26/2008 | US20080153882 Pharmaceutical Composition Comprising Ppar Regulator |
| 06/26/2008 | US20080153881 For therapy of achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia, constipation, cyclic vomiting syndrome, diarrhea, diffuse esophageal spasm, dumping syndrome, dyspepsia, dysphagia, encopresis, fecal incontinence |
| 06/26/2008 | US20080153880 For therapy of achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia, constipation, cyclic vomiting syndrome, diarrhea, diffuse esophageal spasm, dumping syndrome, dyspepsia, dysphagia, encopresis, fecal incontinence |
| 06/26/2008 | US20080153879 Method of managing or treating pain |
| 06/26/2008 | US20080153878 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma |
| 06/26/2008 | US20080153877 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 06/26/2008 | US20080153876 Administering compound such as N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride for inhibiting coagulation |
| 06/26/2008 | US20080153875 Novel indole derivatives and their use as medicament |
| 06/26/2008 | US20080153874 Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| 06/26/2008 | US20080153873 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/26/2008 | US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| 06/26/2008 | US20080153871 Antagonists of the trpv1 receptor and uses thereof |
| 06/26/2008 | US20080153870 Cocaine receptor binding ligands |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153868 Substituted Tetrahydroisoquinolines as Beta-secretase Inhibitors |